Latest Europe News

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Saluda Medical’s Australian arm has secured ASIC approval to bypass standalone audited financial reports, cutting costs and streamlining compliance.

OncoSil Medical’s interim OSPREY Registry data show strong safety and promising survival outcomes for its targeted radiotherapy device in unresectable locally advanced pancreatic cancer, surpassing historical benchmarks.

Advanced Energy Minerals is ramping up its Quebec high purity alumina plant to 3,000 tpa by mid-2026, with plans to double capacity to 6,000 tpa by 2029 amid a tightening global market and supply deficit.

Euro Manganese reveals a strong Preliminary Economic Assessment for its Czech manganese project, highlighting a 48% operating margin and a phased build strategy aimed at meeting soaring battery material demand.

Vista Group International is set to roll out its Digital Enablement platform across 88 Cineworld cinemas in the UK during 2026, building on last year’s deployment at 25 Picturehouse sites.

Smart Parking Limited grew its ANPR sites by 17% in Q3 FY26 and increased parking breach notices by 19%, leveraging acquisitions and AI technology to expand across Europe and New Zealand.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

Arafura Rare Earths has secured a binding offtake term sheet with Traxys North America to supply 500 tonnes per annum of NdPr oxide, underpinning its Nolans Project and supporting US critical minerals supply chains.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

AoFrio’s first quarter revenue plunged 28% year-on-year, weighed down by the loss of a major US motor customer amid tariffs. The refrigeration tech firm is banking on new IoT product launches in Q2 to stabilise sales and improve profitability over 2026.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.